HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jacques Bonneterre Selected Research
Jacques Bonneterre Research Topics
Disease
43
Breast Neoplasms (Breast Cancer)
01/2020 - 10/2002
20
Neoplasms (Cancer)
01/2020 - 09/2005
7
Neoplasm Metastasis (Metastasis)
01/2020 - 10/2002
4
Brain Neoplasms (Brain Tumor)
12/2019 - 01/2013
4
Inflammatory Breast Neoplasms
01/2016 - 09/2010
3
Osteoporosis
10/2019 - 01/2008
3
Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 08/2004
2
Osteoporotic Fractures
10/2019 - 01/2019
2
Endometrial Neoplasms (Endometrial Cancer)
01/2018 - 09/2015
2
Nausea
11/2008 - 12/2006
2
Neutropenia
11/2008 - 12/2006
2
Vomiting
11/2008 - 12/2006
1
Amenorrhea
10/2019
1
Prostatic Neoplasms (Prostate Cancer)
01/2019
1
Dementia (Dementias)
01/2019
1
Parkinson Disease (Parkinson's Disease)
01/2019
1
Meningitis
10/2017
1
Headache (Headaches)
10/2017
1
Melanoma (Melanoma, Malignant)
10/2017
1
Hyperthermia
10/2017
1
Triple Negative Breast Neoplasms
06/2017
1
Thrombotic Microangiopathies
01/2016
1
Endometrioid Carcinoma
09/2015
1
Cognitive Dysfunction
08/2015
1
Pathologic Complete Response
03/2015
1
Adenocarcinoma
01/2015
1
Unilateral Breast Neoplasms
04/2014
1
Lymphedema (Milroy Disease)
07/2011
1
Osteonecrosis (Kienbock's Disease)
01/2008
1
Bone Diseases (Bone Disease)
01/2008
1
Multiple Myeloma
01/2008
Drug/Important Bio-Agent (IBA)
8
Epirubicin (Ellence)
FDA Link
Generic
04/2008 - 01/2004
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2006 - 01/2004
5
Trastuzumab (Herceptin)
FDA Link
12/2019 - 12/2013
5
Capecitabine (Xeloda)
FDA Link
12/2019 - 01/2013
5
Hormones (Hormone)
IBA
10/2019 - 07/2012
5
Progesterone Receptors (Progesterone Receptor)
IBA
01/2018 - 10/2006
5
Anthracyclines
IBA
01/2015 - 12/2006
5
Docetaxel (Taxotere)
FDA Link
01/2015 - 09/2005
4
Taxoids (Taxanes)
IBA
01/2015 - 04/2008
4
Fluorouracil (Carac)
FDA Link
Generic
12/2006 - 08/2004
3
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2020 - 01/2015
3
Vinorelbine (Navelbine)
FDA Link
Generic
12/2019 - 11/2008
3
Diphosphonates (Bisphosphonates)
IBA
10/2019 - 01/2008
3
Proteins (Proteins, Gene)
FDA Link
06/2017 - 12/2011
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
08/2016 - 12/2011
3
Bevacizumab (Avastin)
FDA Link
01/2016 - 01/2015
3
Biomarkers (Surrogate Marker)
IBA
09/2015 - 04/2008
3
Lapatinib (GW572016)
FDA Link
05/2014 - 01/2013
2
Aromatase Inhibitors
IBA
10/2019 - 08/2015
2
Denosumab
FDA Link
10/2019 - 01/2019
2
Estrogens (Estrogen)
FDA Link
10/2019 - 01/2015
2
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
10/2019 - 01/2019
2
Epidermal Growth Factor (EGF)
IBA
12/2017 - 12/2013
2
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
08/2016 - 12/2011
2
Estrogen Receptors
IBA
09/2015 - 10/2006
2
Tamoxifen
FDA Link
Generic
08/2015 - 12/2004
2
Antineoplastic Agents (Antineoplastics)
IBA
09/2011 - 02/2006
2
Paclitaxel (Taxol)
FDA Link
Generic
04/2008 - 01/2004
1
Ado-Trastuzumab Emtansine
IBA
01/2019
1
human ERBB2 protein
IBA
01/2019
1
Glucocorticoids
IBA
01/2019
1
Phenobarbital (Luminal)
FDA Link
01/2019
1
Androgens
IBA
01/2019
1
onapristone
IBA
01/2018
1
TOR Serine-Threonine Kinases
IBA
10/2017
1
Everolimus
FDA Link
10/2017
1
Mechanistic Target of Rapamycin Complex 1
IBA
10/2017
1
dabrafenib
IBA
10/2017
1
Anti-Bacterial Agents (Antibiotics)
IBA
10/2017
1
Progestins (Progestagens)
IBA
09/2015
1
Antigens
IBA
03/2014
1
DNA (Deoxyribonucleic Acid)
IBA
03/2014
1
neratinib
IBA
12/2013
1
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
11/2013
1
Ligands
IBA
07/2012
1
Protein Isoforms (Isoforms)
IBA
07/2012
1
Messenger RNA (mRNA)
IBA
07/2012
1
ErbB Receptors (EGF Receptor)
IBA
07/2012
1
RNA Isoforms
IBA
07/2012
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
12/2011
1
Cell Adhesion Molecules
IBA
12/2011
1
Cytokines
IBA
12/2011
1
Interleukin-12 (IL 12)
IBA
12/2011
1
Alkaloids
IBA
11/2008
1
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2008
1
thiamine triphosphorate (TTP)
IBA
04/2008
1
Alendronate (Alendronate Sodium)
FDA Link
Generic
01/2008
Therapy/Procedure
20
Drug Therapy (Chemotherapy)
01/2020 - 08/2004
15
Therapeutics
01/2020 - 10/2002
11
Adjuvant Chemotherapy
01/2019 - 03/2003
4
Neoadjuvant Therapy
01/2016 - 01/2012
3
Radiotherapy
08/2015 - 01/2013
1
Duration of Therapy
01/2018
1
Lasers (Laser)
06/2017
1
Salvage Therapy
11/2013
1
Spinal Injections
09/2011
1
Aftercare (After-Treatment)
07/2011
1
Cardiopulmonary Resuscitation (CPR)
09/2010
1
Brachytherapy
01/2009